Thus, increasing Hsp levels in neurons and glial cells has been investigated as an attractive therapeutic target for protein misfolding diseases such as ALS (Kalmar et al. 2014; Kieran et al. 2004; Waza et al. 2005). The gene discussed is HSP90B2P; the disease is proteostasis deficiencies.